期刊
MOLECULAR NUTRITION & FOOD RESEARCH
卷 52, 期 8, 页码 913-920出版社
WILEY
DOI: 10.1002/mnfr.200700132
关键词
Lactococcus lactis; local delivery system; pIgR; recombinant; ScFv SIgA
资金
- Ubbo Emmius Foundation
- IAG action programme of the Province of Groningen
- TOP institute Pharma
- ALW levenswetenschappen
- Maag-Lever-Darm Foundation
- The Netherlands
- Dutch Technology Foundations STW [6848]
The gastrointestinal tract is a complex niche and the main port of entry of many pathogens that trigger a wide range of diseases like inflammatory bowel disease (IBD) and colon cancer. Antibodies are effective for treating such diseases, but a System capable of local delivery at the site of the pathology, thus avoiding systemic side effects, is not yet available. Here we report a novel recombinant scFvSIgA1 protein produced by Lactococcus lactis, anchored to the bacterial membrane, which retains its full immuno-recognizing potential. This scFv fragment employed was specific for a colon cancer epilope, epithelial glycoprotein protein-2 (EGP-2). Accordingly L. lactis expressing this chimeric protein was capable of binding cells expressing this epitope. Expression of specific antibodies on bacteria may allow local delivery of anticancer agents produced by Such bacteria ill Conjunction with the antibody and provides a new avenue in the quest for targeted drug delivery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据